Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021

Healthcare Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021

Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth

INDUSTRY
Healthcare

RELEASE DATE
30-Nov-2017
REGION
Europe
DELIVERABLE TYPE
Market Research

RESEARCH CODE
MD52-01-00-00-00
SKU
HC02934-EU-MR_21200
Yes
SHARE

$3,000.00

Special Price $2,250.00 save 25 %

In stock
SKU
HC02934-EU-MR_21200

Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Published on: 30-Nov-2017 | SKU: HC02934-EU-MR_21200

Need more details?

$3,000.00

$2,250.00 save 25 %

DownloadLink
Need more details?

Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanced maternal age (over 35 years) and considerable popularity through social media and e-commerce channels. High level of merger and acquisition activity apart from numerous collaborations with regional clinical labs has supported the participants in marketing their products across the European region. Moreover, companies are also exploring new avenues to market their product by strategically tying up with IVF clinics, physicians, genetic counsellors and OBGYNs. Partnership with big data companies is anticipated to be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity, sensitivity, and cost of tests. The key business model emerging across the market is the collaboration of key participants with regional private clinical labs as well as public centres and organizations such as NHS to increase the market coverage in Europe.


Research Scope

The key objectives of this growth insights study are to track the transformations in the prenatal genetic test market landscape in Europe for 2016-2021. The study aims at identifying growth opportunities across the market and suggesting most profitable business models to market players. Furthermore, the study provides an in-depth revenue and market analysis of 4 key segments within the prenatal landscape: NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers, restraints, competitive developments, key mergers and acquisitions (M&As), and investment opportunities. Key trends across the market with respect to physician and patient attitudes toward prenatal genetic screening and its probable impact on growth are analyzed. Additionally, top growth opportunities, profiles of game-changing companies, disruptive technologies and innovative business models, along with strategic recommendations are included.

Key Issues Addressed

  • Which are the most promising segments in the EU prenatal genetic testing market? Where is the most interest in terms of funding and innovation?
  • What are the most favorable business models across the prenatal testing market in Europe? How are companies coping with the market drawbacks and needs?
  • What are some of the most disruptive products in this market? Who are the key players in the market?
  • What are the gaps in the market that encourage penetration and provide opportunities to new entrants?

Purpose of This Experiential Study

5-Step Process to Transformational Growth

Scope and Segmentation

Overview of Segments

Market Engineering Measurements

Methodology

Key Findings—A Highly Consolidated Market

Market Dynamics—Steady but Strong Growth

Comparison with the US Market

Impact Analysis—Key Growth Contributors

Prevalence of Foetal Chromosomal Aneuploidies

Regulatory Landscape—Most Promising Markets

Termination of Pregnancy Laws—Regional Variations

Drivers and Restraints—Technology Driven Market

Key Market Challenges

Market Engineering Measurements

Revenue Forecast

Market Share by Type of Prenatal Genetic Tests

Emerging Business Models

Competitive Factors and Assessment

Key Mergers & Acquisitions and Partnerships

Segment Overview

Revenue Forecast

Snapshot of Key Market Participants

Macro to Micro Visioning

Trend Analysis in Prenatal Genetic Testing Market

Transformation in Industry Eco-system

Strategic Imperatives for Market Growth

5 Major Growth Opportunities

Growth Opportunity Matrix

Top Predictions for the EU Prenatal Genetic Testing Market

Legal Disclaimer

Abbreviations and Acronyms Used

List of Figures
  • 1. Prenatal Genetic Testing Market: Comparison with the US Market, Europe, 2016
  • 2. Prenatal Genetic Testing Market: Regulatory Landscape, Europe, 2016
  • 3. Prenatal Genetic Testing Market: Drivers and Restraints, Europe, 2017–2021
  • 4. Prenatal Genetic Testing Market: Competitive Factors and Assessment, Europe, 2016
  • 5. Prenatal Genetic Testing Market: Key Mergers & Acquisitions and Partnerships, Europe, 2016-2017
List of Charts
  • 1. Prenatal Genetic Testing Market: Market Engineering Measurements, Europe, 2016
  • 2. Prenatal Genetic Testing Market: Impact Analysis, Europe, 2016
  • 3. Prenatal Genetic Testing Market: Prevalence of Foetal Chromosomal Aneuploidies, Europe, 2016
  • 4. Prenatal Genetic Testing Market: Termination of Pregnancy Laws, Europe, 2016
  • 5. Prenatal Genetic Testing Market: Key Market Challenges, Europe, 2016
  • 6. Prenatal Genetic Testing Market: Market Engineering Measurements, Europe, 2016
  • 7. Prenatal Genetic Testing Market: Revenue Forecast, Europe, 2016–2021
  • 8. Prenatal Genetic Testing Market: Market Share Analysis by Tests, Europe, 2016
  • 9. Prenatal Genetic Testing Market: Market Share Analysis by Tests, Europe, 2021
  • 10. Prenatal Genetic Testing Market: Emerging Business Models, Europe, 2016-2021
  • 11. Non-invasive Prenatal Testing Market: Revenue Forecast, Europe, 2016–2021
  • 12. Non-invasive Prenatal Testing Market: Snapshot of Key Market Participants, Europe, 2016
  • 13. Carrier Screening Test for Cystic Fibrosis Market: Revenue Forecast, Europe, 2016–2021
  • 14. Carrier Screening Tests for Cystic Fibrosis Market: Snapshot of Key Market Participants, Europe, 2016
  • 15. Invasive Prenatal Testing Market: Revenue Forecast, Europe, 2016–2021
  • 16. Invasive Prenatal Testing Market: Snapshot of Key Market Participants, Europe, 2016
  • 17. Miscarriage Testing Market: Revenue Forecast, Europe, 2016–2021
  • 18. Miscarriage Testing Market: Snapshot of Key Market Participants, Europe, 2016
  • 19. Prenatal Genetic Testing Market: Trend Analysis, Europe, 2016-2021
  • 20. Prenatal Genetic Testing Market: Growth Opportunity Matrix, Europe, 2016

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related In Vitro Diagnostics (IVD) research

21 Jul 2026   |   Global   |   Market Research

Point-of-Care Testing Market, Global, 2024–2031

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...

17 Jul 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age...

08 Jul 2026   |   Global   |   Technology Research

Precision Obesity Management: AI-Guided Metabolic Modulation

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and envir...

25 Jun 2026   |   Global   |   Technology Research

Quantum Sensors Transitioning from Lab to Industry: Ultra-Precision Measurement for Healthcare, Defense, and Manufacturing

Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environmen...

22 Jun 2026   |   Global   |   Market Research

Growth Opportunities, Global Life Sciences LIMS Market, Forecast to 2031

The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions.

Leading players in the global life sciences L...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanced maternal age (over 35 years) and considerable popularity through social media and e-commerce channels. High level of merger and acquisition activity apart from numerous collaborations with regional clinical labs has supported the participants in marketing their products across the European region. Moreover, companies are also exploring new avenues to market their product by strategically tying up with IVF clinics, physicians, genetic counsellors and OBGYNs. Partnership with big data companies is anticipated to be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity, sensitivity, and cost of tests. The key business model emerging across the market is the collaboration of key participants with regional private clinical labs as well as public centres and organizations such as NHS to increase the market coverage in Europe.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Table of Contents | Executive Dashboard~ || Purpose of This Experiential Study~ || 5-Step Process to Transformational Growth~ || Scope and Segmentation~ || Overview of Segments~ || Market Engineering Measurements~ | Growth Environment—Market Overview ~ || Methodology~ || Key Findings—A Highly Consolidated Market~ || Market Dynamics—Steady but Strong Growth ~ || Comparison with the US Market~ || Impact Analysis—Key Growth Contributors~ || Prevalence of Foetal Chromosomal Aneuploidies~ || Regulatory Landscape—Most Promising Markets~ || Termination of Pregnancy Laws—Regional Variations~ || Drivers and Restraints—Technology Driven Market~ || Key Market Challenges ~ | Growth Environment—Market Forecasts~ || Market Engineering Measurements~ || Revenue Forecast~ || Market Share by Type of Prenatal Genetic Tests~ | Growth Environment—Competitive Playbook~ || Emerging Business Models ~ || Competitive Factors and Assessment ~ || Key Mergers & Acquisitions and Partnerships~ | Growth Environment—Non-invasive Prenatal Testing Market~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Market Participants~ | Growth Environment—Carrier Screening Tests for Cystic Fibrosis Market ~ | Growth Environment—Invasive Prenatal Testing Market~ | Growth Environment—Miscarriage Testing Market~ | Visioning Scenarios~ || Macro to Micro Visioning~ || Trend Analysis in Prenatal Genetic Testing Market~ | Growth Environment and Companies to Action~ || Transformation in Industry Eco-system~ || Strategic Imperatives for Market Growth~ || 5 Major Growth Opportunities~ || Growth Opportunity Matrix~ | The Last Word~ || Top Predictions for the EU Prenatal Genetic Testing Market ~ || Legal Disclaimer~ | Appendix~ || Abbreviations and Acronyms Used~ | The Frost & Sullivan Story~
List of Charts and Figures 1. Prenatal Genetic Testing Market: Comparison with the US Market, Europe, 2016~ 2. Prenatal Genetic Testing Market: Regulatory Landscape, Europe, 2016~ 3. Prenatal Genetic Testing Market: Drivers and Restraints, Europe, 2017–2021~ 4. Prenatal Genetic Testing Market: Competitive Factors and Assessment, Europe, 2016~ 5. Prenatal Genetic Testing Market: Key Mergers & Acquisitions and Partnerships, Europe, 2016-2017~| 1. Prenatal Genetic Testing Market: Market Engineering Measurements, Europe, 2016~ 2. Prenatal Genetic Testing Market: Impact Analysis, Europe, 2016~ 3. Prenatal Genetic Testing Market: Prevalence of Foetal Chromosomal Aneuploidies, Europe, 2016~ 4. Prenatal Genetic Testing Market: Termination of Pregnancy Laws, Europe, 2016~ 5. Prenatal Genetic Testing Market: Key Market Challenges, Europe, 2016~ 6. Prenatal Genetic Testing Market: Market Engineering Measurements, Europe, 2016~ 7. Prenatal Genetic Testing Market: Revenue Forecast, Europe, 2016–2021~ 8. Prenatal Genetic Testing Market: Market Share Analysis by Tests, Europe, 2016~ 9. Prenatal Genetic Testing Market: Market Share Analysis by Tests, Europe, 2021~ 10. Prenatal Genetic Testing Market: Emerging Business Models, Europe, 2016-2021~ 11. Non-invasive Prenatal Testing Market: Revenue Forecast, Europe, 2016–2021~ 12. Non-invasive Prenatal Testing Market: Snapshot of Key Market Participants, Europe, 2016~ 13. Carrier Screening Test for Cystic Fibrosis Market: Revenue Forecast, Europe, 2016–2021~ 14. Carrier Screening Tests for Cystic Fibrosis Market: Snapshot of Key Market Participants, Europe, 2016~ 15. Invasive Prenatal Testing Market: Revenue Forecast, Europe, 2016–2021~ 16. Invasive Prenatal Testing Market: Snapshot of Key Market Participants, Europe, 2016~ 17. Miscarriage Testing Market: Revenue Forecast, Europe, 2016–2021~ 18. Miscarriage Testing Market: Snapshot of Key Market Participants, Europe, 2016~ 19. Prenatal Genetic Testing Market: Trend Analysis, Europe, 2016-2021~ 20. Prenatal Genetic Testing Market: Growth Opportunity Matrix, Europe, 2016~
Author Aarti Chitale
Industries Healthcare
WIP Number MD52-01-00-00-00
Is Prebook No